Loading company…
Origingene develops clinical diagnostic technologies and provides related research and testing services.
Founded in 2019, Origingene develops clinical diagnostic technologies and provides research and testing services, including technologies in NGS and isothermal amplification. The company is based in Shanghai, China, and has developed tumor and pathogenic microbial databases. It raised over CNY 10 million in angel funding in December 2024, following a strategic investment in July 2024 from HY Capital and Shanghai Yijian Biomedical Technology.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in